Views

April 2021 Event Summary Available to Download

April 2021 Event Summary Available to Download

Embedding patient journeys into clinical and commercial planning, for more focused decisions and improved patient outcomes.

On April 21st, 2021 Cello Health hosted its first ‘Pharma Progress’ – a brand new virtual event aiming to explore some of healthcare’s most imperative challenges and how these are being addressed. Our first topic focussed on the patient and the patient journey. The speaker and panellist discussions were both dynamic and insightful, and we have captured the key themes and discussion points in a summary paper available for you to download now.

Download from Pharma Progress

Share this

Related Articles

Alzheimer’s and Dementia: A Snapshot of the Science and Shape of the Future
10 January 2022
Alzheimer’s and Dementia: A Snapshot of the Science and Shape of the Future

Read our interview on Alzheimer’s and dementia with Dr. Ashby, who leads a research group within the School of Physiology, Pharmacology and Neuroscience at the University of Bristol by completing the form below.

Cello Health Announces New Syndicated Research Program
12 November 2021
Cello Health Announces New Syndicated Research Program

Cello Health has developed a suite of syndicated offerings tailored to support your strategic objectives at key stages in the product lifecycle. Our customizable group of reports will provide regular actionable insights from market landscape maps based on social media data, as well as ongoing tracking of HCP preferences and channel behavior.

The US Forecaster’s Check List for Japan: A World of Difference
24 September 2021
The US Forecaster’s Check List for Japan: A World of Difference

The US Forecaster’s Check List for Japan: A World of Difference

Expanding the valuation of a biopharmaceutical asset to Japan requires a new mindset in nearly every input of forecasting, with many pitfalls. Doug Willson, Senior Vice President, Cello Health Advantage and Tiffany Ahlers, Chief Commercial Officer, Mycovia Pharmaceuticals Inc., share a checklist to improve the rigor and validity of product forecasts for Japan.

Let’s work together

The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us today

Contact us